Seguir
E.E. Giorgi
E.E. Giorgi
Dirección de correo verificada de lanl.gov
Título
Citado por
Citado por
Año
Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus
B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, ...
Cell 182 (4), 812-827. e19, 2020
34192020
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection
BF Keele, EE Giorgi, JF Salazar-Gonzalez, JM Decker, KT Pham, ...
Proceedings of the National Academy of Sciences 105 (21), 7552-7557, 2008
21572008
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection
JF Salazar-Gonzalez, MG Salazar, BF Keele, GH Learn, EE Giorgi, H Li, ...
Journal of Experimental Medicine 206 (6), 1273-1289, 2009
9132009
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
N Goonetilleke, MKP Liu, JF Salazar-Gonzalez, G Ferrari, E Giorgi, ...
Journal of experimental medicine 206 (6), 1253-1272, 2009
7712009
Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2
B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, ...
BioRxiv, 2020
4692020
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants
MR Abrahams, JA Anderson, EE Giorgi, C Seoighe, K Mlisana, LH Ping, ...
Journal of virology 83 (8), 3556-3567, 2009
4632009
Phenotypic properties of transmitted founder HIV-1
NF Parrish, F Gao, H Li, EE Giorgi, HJ Barbian, EH Parrish, L Zajic, ...
Proceedings of the National Academy of Sciences 110 (17), 6626-6633, 2013
4312013
Emergence of SARS-CoV-2 through recombination and strong purifying selection
X Li, EE Giorgi, MH Marichannegowda, B Foley, C Xiao, XP Kong, Y Chen, ...
Science advances 6 (27), eabb9153, 2020
4042020
Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys
DH Barouch, KE Stephenson, EN Borducchi, K Smith, K Stanley, ...
Cell 155 (3), 531-539, 2013
3312013
High multiplicity infection by HIV-1 in men who have sex with men
H Li, KJ Bar, S Wang, JM Decker, Y Chen, C Sun, JF Salazar-Gonzalez, ...
PLoS pathogens 6 (5), e1000890, 2010
3272010
Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing
W Fischer, VV Ganusov, EE Giorgi, PT Hraber, BF Keele, T Leitner, ...
PloS one 5 (8), e12303, 2010
3192010
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1
BF Keele, H Li, GH Learn, P Hraber, EE Giorgi, T Grayson, C Sun, Y Chen, ...
Journal of Experimental Medicine 206 (5), 1117-1134, 2009
3142009
Sheffield COVID-19 Genomics Group
B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, ...
Tracking changes in SARS-CoV-2 spike: evidence that D614G increases …, 2020
2242020
Modeling sequence evolution in acute HIV-1 infection
HY Lee, EE Giorgi, BF Keele, B Gaschen, GS Athreya, ...
Journal of theoretical biology 261 (2), 341-360, 2009
2162009
HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC
N Wood, T Bhattacharya, BF Keele, E Giorgi, M Liu, B Gaschen, ...
PLoS pathogens 5 (5), e1000414, 2009
2112009
Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection
EO Saphire, SL Schendel, ML Fusco, K Gangavarapu, BM Gunn, AZ Wec, ...
Cell 174 (4), 938-952. e13, 2018
1592018
Human non-neutralizing HIV-1 envelope monoclonal antibodies limit the number of founder viruses during SHIV mucosal infection in rhesus macaques
S Santra, GD Tomaras, R Warrier, NI Nicely, HX Liao, J Pollara, P Liu, ...
PLoS pathogens 11 (8), e1005042, 2015
1442015
Role of donor genital tract HIV-1 diversity in the transmission bottleneck
DI Boeras, PT Hraber, M Hurlston, T Evans-Strickfaden, T Bhattacharya, ...
Proceedings of the National Academy of Sciences 108 (46), E1156-E1163, 2011
1342011
Estimating time since infection in early homogeneous HIV-1 samples using a poisson model
EE Giorgi, B Funkhouser, G Athreya, AS Perelson, BT Korber, ...
BMC bioinformatics 11 (1), 1-7, 2010
962010
HIV-1 neutralizing antibody signatures and application to epitope-targeted vaccine design
CA Bricault, K Yusim, MS Seaman, H Yoon, J Theiler, EE Giorgi, K Wagh, ...
Cell host & microbe 25 (1), 59-72. e8, 2019
942019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20